Increased values of the circulating PDGFβ sustains the “withdrawal syndrome” after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia

2015 ◽  
Vol 55 (3) ◽  
pp. 211-212 ◽  
Author(s):  
Sara Galimberti ◽  
Giulia Fontanelli ◽  
Sara Barsotti ◽  
Federica Ricci ◽  
Francesca Guerrini ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Withdrawal Syndrome ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Tyrosine Kinase Inhibitor Discontinuation

scholarly journals Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

2020 ◽  
Vol 11 (12) ◽  
pp. 996-1007
Author(s):  
Ruth Stuckey ◽  
Juan Francisco López-Rodríguez ◽  
Santiago Sánchez-Sosa ◽  
Adrián Segura-Díaz ◽  
Nuria Sánchez-Farías ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Tyrosine Kinase Inhibitor Discontinuation ◽  
Predictive Indicators
Sign in / Sign up

Export Citation Format

Share Document